Sulfatases Market - Global Forecasts from 2023 to 2028

The global sulfatases market is estimated to grow at a CAGR of 6.51% during the forecast period

The global sulfatases market is expected to grow at a steady pace during the forecast period. Sulfatases play a crucial role in sulfate metabolism. The deficiency of sulfatases in the human body causes various diseases including Lysosomal storage disorders. The rising diseases and continuous scientific research are anticipated to boost the sulfatases market growth. Further, the technological adoption and growing concern about food safety are supposed to propel the sulfatases market size.

Growing Need in the Pharmaceuticals Industry

The sulfatases are extremely useful in the pharmaceutical industry due to their property of synthesizing intermediates in active pharmaceutical ingredients. Recently, two anti-viral drugs RPI -27 and RPI-28 that inhibit SARS-Cov-2 were derived from fucoidans (sulfatase enzyme). There are congenital disorders occurrence in animals such as visceral manifestation, HS accumulation, and metachromatic disorders caused by deficiency of sulfatases. For the treatment of these disorders, the use of sulfatases is necessary as it acts as a catalyst enzyme. This usage in the pharmaceutical industry with phenomenal benefits is expected to boost the sulfatases market growth.

Wider Application use of these sulfatases will drive market growth

Sulfatases are used for their properties in various industries such as pharmaceutical, agriculture, oil and chemical industry, detergents, biofuel production, and paper and pulp industry. Due to its chemical property to remove fat and oil stains, it is used in detergents. Moreover, it degrades sulfur-containing compounds that are present in the environment and the degradation of glycolipids in the lysosome of cells. Sufatases act as a biocatalyst in the marine environment by metabolically transforming abundant sulfated algal polysaccharides into monosaccharides. These monosaccharides can enter energy-yielding metabolic pathways. The multiple uses of sulfatases in various sectors are contemplated to boost the sulfatase market size during the forecasted year.

Growing Demand in the Agriculture Sector will act as a growth driver

The demand for agricultural products is increasing with the growing population. According to the UN Food and Agricultural Organization, the food demand will increase by 50% by the year 2050. Sulfatases are used in the agriculture sector as an enzyme that breaks down aromatic sulfate esters phenols and sulfate present in the soil. The glucosinolate sulfatases are used by cruciferous plants to defend themselves from herbivory, insects, and other organisms thereby increasing the yield. The strategy to convert glucosinolate into inactive desulfoglucosinolates is used by plants against phloem-feeding insects. These advantages of sulfatases in the agricultural sector are supposed to propel the sulfatases market size.

Constant Research and Technological Advancements are further acting as growth drivers

Several research projects and experiments are happening in the sulfatases market. Sulfatlas is a database of sulfatases developed by Sorbonne University and released in 2013. Currently, the Sulfatlas database contains more than 1.5 lakh entries of available sulfatase sequences. In October 2021, a study by the National Centre for Biotechnology Information showed that a single sulfatase is required to utilize mucin glycoproteins by gut bacteria. Moreover, research has shown that single sulfatase is essential to utilize glycans in vitro and in vivo. Recently, sulfatases have been found to be of greater utility in the investigation of drugs, doping control analysis, and metabolomics due to their link between metabolic processes and pathophysiological conditions in humans. This research and the discovery of utilization of sulfatases in various processes are contemplated to boost the sulfatases market.

Opportunities in the market

The continuous research and experiments to discover the potential of sulfatases in all possible ways are providing growth opportunities in the sulfatases market. Moreover, the government investments and adoption of the Internet of Things by the major market players to enhance their products using sulfatases and rapid development is another major growth opportunity in the sulfatase market. The rising awareness and the health-related issues coupled with the rising cases of developmental abnormalities are further expected to provide a positive growth opportunity in the sulfatases market.

North America is expected to emerge as a significant market

The North American region is expected to contribute a major share and significant share in the global sulfatases market. Various factors attributing to the significant share are recent advancements of protein engineering in the biotechnology sector, other related technological advancements, government-backed initiatives, and research projects. Moreover, the presence of various crop science companies and healthcare leading companies such as Compass Minerals, 3M, Abbott Laboratories, and others which inculcate sulfatases in their production makes North America a major contributing region in the sulfatases market.

Sulfatases Market Key Players

• Novozymes established in 1983 is one of the largest biotechnology companies that supply industrial enzymes and microorganisms. The company provides bio-solutions that transform industrial and consumer processes. The product offered by the company is recombinant insulin, CTAB, cetrimide, and benzalkonium chloride.
• Bayer AG provides tailored solutions to each farmer. It offers crop protection, sustainable farming techniques, and healthcare solutions through Aleve, Alka Seltzer, Bepanthen, Acceleron, Afrin, Adempas, and several other brands.
• Sumitomo Chemicals is a Japan-based company that provides solutions in essential chemicals and plastics, energy and functional material, IT-related chemicals, health and crop sciences, and pharmaceuticals.  The company offers rubber chemicals, paper processing resins, Sumikasuper LCP, medical films, sumiploy, Summit-L feed additives, and others.

Key Market Developments

• In September 2022, a study conducted by WSU College of Pharmacy identified a protein known as sulfatase-2 that is used to ease rheumatoid arthritis symptoms. This research also opens the way for the development of therapies with sulfatase-2 to prevent bone loss, cartilage damage, and deformed joints.  

Segmentation:

By Function

• Hormone Regulation
• Cellular Degradation
• Modulation of Signalling Pathways

By Application

• Hormone-Dependent Cancers
• Lysosomal Storage Disorders
• Developmental Abnormalities
• Bacterial Pathogenesis

By End-User

• Hospitals
• Ambulatory Surgical Centres
• Others

By Geography

• North America
• United States
• Canada
• Mexico
• South America
• Brazil
• Argentina
• Others
• Europe
• United Kingdom
• Germany
• France
• Spain
• Others
• Middle East and Africa
• Saudi Arabia
• UAE
• Israel
• Others
• Asia Pacific
• Japan
• China
• India
• South Korea
• Indonesia
• Thailand
• Others